Non-Current Assets
Total Assets
Alnylam Pharmaceuticals Total Assets increased by 3.3% to $5.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.7%, from $4.21B to $5.13B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 7.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
Metric ID:
total_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.51B | $3.47B | $3.64B | $3.43B | $3.33B | $3.54B | $3.55B | $3.39B | $3.40B | $3.84B | $3.83B | $3.82B | $4.01B | $4.21B | $4.24B | $4.21B | $4.57B | $4.85B | $4.97B | $5.13B |
| QoQ Change | — | -1.1% | +4.9% | -5.8% | -3.0% | +6.2% | +0.3% | -4.4% | +0.3% | +12.8% | -0.2% | -0.1% | +4.8% | +4.9% | +0.8% | -0.6% | +8.4% | +6.3% | +2.4% | +3.3% |
| YoY Change | — | — | — | — | -5.1% | +1.8% | -2.7% | -1.2% | +2.2% | +8.6% | +8.0% | +12.7% | +17.8% | +9.5% | +10.7% | +10.2% | +13.9% | +15.4% | +17.1% | +21.7% |
Range$3.33B – $5.13B
CAGR+8.3%
Avg YoY Growth+8.8%
Median YoY Growth+9.9%
Current Streak4 quarters growth
Total Assets at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's total assets?
- Alnylam Pharmaceuticals (ALNY) reported total assets of $5.13B in Q1 2026.
- How has Alnylam Pharmaceuticals's total assets changed year-over-year?
- Alnylam Pharmaceuticals's total assets increased by 21.7% year-over-year, from $4.21B to $5.13B.
- What is the long-term trend for Alnylam Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's total assets has grown at a 7.8% compound annual growth rate (CAGR), from $3.41B to $4.97B.